A Study about the Liver and Kidney safety of patients taking siddha metallic drugs for long duratio
Phase 1
- Conditions
- Health Condition 1: null- Taking Siddha metallic drug preparations for 2 months and above duration for any disease and those who are not taking any allopathic medication for long duration
- Registration Number
- CTRI/2017/03/008160
- Lead Sponsor
- Dr P Parvathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1) GROUP A Patients who are taking Siddha metallic drug preparations for more than two months and above duration up to one year
2) GROUP B Patients who had taken Siddha metallic drugs for 2 months to one year duration and have not taken metallic drugs for the last one year
Exclusion Criteria
1) In Group A Patients with hepato renal pathology
2) Presence of any major illness which affects the clinical parameters
3)Patients who are undergoing allopathic medication and have underwent alopathic medications for one month duration
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Will be observed from the parameters used for assessment Both Siddha parameters and modern laboratory parametersTimepoint: 1 year
- Secondary Outcome Measures
Name Time Method Will be observed from the parameters used for the assessment both Siddha parameters and modern diagnostic parametersTimepoint: Study duration is one year <br/ ><br>Patients who are taking metallic Siddha drug preparations for more than two months duration are included in the study